Skip to main content
. 2022 Oct 21;11(1):292–305.e2. doi: 10.1016/j.jaip.2022.10.010

TABLE II.

Immunological data on 60 patients with 22q11.2DS

Laboratory data n (%)
Neutropenia (<1,000 cell/mm3) 0
Lymphopenia (<1,500 cell/mm3), n (%) 20 (38)
IgG < 700 mg/dL, n (%) 4 (8)
IgA < 68 mg/dL, n (%) 2 (4)
IgM < 40 mg/dL, n (%) 8 (16)
CD4+ count (cell/mm3), median (IQR) 585 (478–797)
 ≥600 cells/mm3, n (%) 20 (49)
 400–600 cells/mm3, n (%) 14 (34)
 <400 cells/mm3, n (%) 7 (17)
CD8+ count (cells/mm3), median (IQR) 358 (258–494)
 <420 cells/mm3, n (%) 24 (61.5)
CD19+ count (cells/mm3), median (IQR) 216 (159–308)
 <90 cells/mm3, n (%) 1 (3)